Experts who reviewed studies on NSAIDs and breast cancer have concluded that there is sufficient evidence to suggest that these popular non-prescription drugs could, if used correctly, play an important role in preventing and treating breast cancer.
They suggest that they could reduce breast cancer by up to 20 percent. The 27-year review covers 21 studies of 37,000 women.
But further research is needed to see if the risks outweigh the benefits.